Evaluation of new medicinal products in the treatment of primary osteoporosis

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Currently under revision - see below

Reference numberCPMP/EWP/552/95 Rev. 2
Published16/11/2006
Effective from31/05/2007
KeywordsPost-menopausal osteoporosis, osteopenia, bone mineral density, fractures
DescriptionThis document provides guidance for the evaluation of new medicinal products in the treatment of primary osteoporosis, principally in postmenopausal women but also in men.


Document history

Revision 3 

In progress

Concept paperPublished: 31/10/2012

Revision 2 

Current version

Adopted guideline


Overview of comments


Draft guideline

In operation: 31/05/2007–present


Published: 16/11/2006


Published: 14/12/2005


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more